# FDA recall D-0963-2022

> **Nephron Sterile Compounding Center LLC** · Class II · drug recall initiated 2022-05-18.

## Product

Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL (1 mg/mL), Preservative Free, 5 mL Pre-Filled Syringe, 5 x 5 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-902-05

## Reason for recall

Lack of Assurance of Sterility

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0963-2022
- **Recalling firm:** Nephron Sterile Compounding Center LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-05-18
- **Report date:** 2022-06-08
- **Termination date:** 2024-08-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** West Columbia, SC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0963-2022

## Citation

> AI Analytics. FDA recall D-0963-2022. Retrieved 2026-06-05 from https://api.ai-analytics.org/recall/D-0963-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*